Association between basal thinning of interventricular septum and adverse long-term clinical outcomes in patients with cardiac sarcoidosis

Circulation Journal

Volumn 79, Issue 7, 2015, Pages 1601-1608

  Nagano, Nobutaka ^a   Nagai, Toshiyuki ^a   Sugano, Yasuo ^a   Morita, Yoshiaki ^a   Asaumi, Yasuhide ^a   Aiba, Takeshi ^a   Kanzaki, Hideaki ^a   Kusano, Kengo ^a   Noguchi, Teruo ^a   Yasuda, Satoshi ^a   Ogawa, Hisao ^a,b   Anzai, Toshihisa ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cardiomyopathy; Echocardiography; Heart failure; Sarcoidosis

Indexed keywords

AGED; CARDIOMYOPATHY; CLINICAL TRIAL; DISEASE FREE SURVIVAL; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE SEPTUM; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; SARCOIDOSIS; SURVIVAL RATE;

AGED; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS; SURVIVAL RATE;

EID: 84934300445     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-1217     Document Type: Article

References (38)

1. Fleming HA. Sarcoid heart disease. Br Heart J 1974; 36: 54-68.
2. Lorell B, Alderman EL, Mason JW. Cardiac sarcoidosis: Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol 1978; 42: 143-146.
3. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-1211.
4. Vignaux O. Cardiac sarcoidosis: Spectrum of MRI features. Am J Roentgenol 2005; 184: 249-254.
5. Valantine H, McKenna WJ, Nihoyannopoulos P, Mitchell A, Foale RA, Davies MJ, et al. Sarcoidosis: A pattern of clinical and morphological presentation. Br Heart J 1987; 57: 256-263.
6. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart: A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977; 63: 86-108.
7. Hiraga H, Iwai K, Hiroe M, Takada K, Omori F, Yazaki Y, et al. Guideline for the diagnosis of cardiac sarcoidosis: Study report on diffuse pulmonary disease. Japan Ministry Health Welfare. Tokyo, 1993; 23-24
8. Sekiguchi M, Numao Y, Imai M, Furuie T, Mikami R. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis: Concepts through a study employing endomyocardial biopsy. I: Sarcoidosis. Jpn Circ J 1980; 44: 249-263.
9. Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivisto SM, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011; 270: 461-468.
10. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683-1690.
11. Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995; 107: 330-334.
12. Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, et al. Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing. Chest 2008; 133: 1426-1435.
13. Ohira H, Mc Ardle B, Cocker MS, deKemp RA, Dasilva JN, Beanlands RS. Current and future clinical applications of cardiac positron emission tomography. Circ J 2013; 77: 836-848.
14. Miyagawa M, Yokoyama R, Nishiyama Y, Ogimoto A, Higaki J, Mochizuki T. Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases. Circ J 2014; 78: 1302-1310.
15. 18F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis. Eur J Nucl Med Mol Imaging 2013; 40: 1558-1566.
16. Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014; 63: 329-336.
17. 18F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis. Ann Nucl Med 2014; 28: 656-663.
18. 18F-fluorodoexyglucose positron emission tomography? Circ Cardiovasc Imaging 2013; 6: 617-626.
19. Greulich S, Deluigi CC, Gloekler S, Wahl A, Zurn C, Kramer U, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2013; 6: 501-511.
20. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009; 120: 1969-1977.
21. Ise T, Hasegawa T, Morita Y, Yamada N, Funada A, Takahama H, et al. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart 2014; 100: 1165-1172.
22. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-1010.
23. Schuller JL, Lowery CM, Zipse M, Aleong RG, Varosy PD, Weinberger HD, et al. Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis. Ann Noninvasive Electrocardiol 2011; 16: 70-76.
24. Morimoto S, Uemura A, Sugimoto K, Ishii J, Hiramitsu S, Katoh Y, et al. A proposal for diagnostic criteria of basal thinning of the interventricular septum in cardiac sarcoidosis: A multicenter study. Circ J 2006; 70(Suppl I): 215.
25. Tsuda T, Ishihara M, Okamoto H, Ohara K, Oritsu M, Sugiura K, et al. Diagnostic criteria and guideline for sarcoidosis-2006. Jpn J Sarcoidosis Other Granulomatous Dis 2006; 27: 89-102 (in Japanese).
26. Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005; 26: 1538-1543.
27. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
28. Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 24-31.
29. Nureki S, Miyazaki E, Nishio S, Ehara C, Yamasue M, Ando M, et al. Interventricular septal thickening as an early manifestation of cardiac sarcoidosis. Int Heart J 2014; 55: 181-183.
30. Yazaki Y, Isobe M, Hayasaka M, Tanaka M, Fujii T, Sekiguchi M. Cardiac sarcoidosis mimicking hypertrophic cardiomyopathy: Clinical utility of radionuclide imaging for differential diagnosis. Jpn Circ J 1998; 62: 465-468.
31. Matsumori A, Hara M, Nagai S, Izumi T, Ohashi N, Ono K, et al. Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. Jpn Circ J 2000; 64: 679-683.
32. Miyazaki S, Funabashi N, Nagai T, Uehara M, Kataoka A, Takaoka H, et al. Cardiac sarcoidosis complicated with atrioventricular block and wall thinning, edema and fibrosis in left ventricle: Confirmed recovery to normal sinus rhythm and visualization of edema improvement by administration of predonisolone. Int J Cardiol 2011; 150: e4-e10, doi:10.1016/j.ijcard.2009.05.047.
33. Uemura A, Morimoto S, Kato Y, Hiramitsu S, Ohtsuki M, Kato S, et al. Relationship between basal thinning of the interventricular septum and atrioventricular block in patients with cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 63-65.
34. Kinney E, Murthy R, Ascunce G, Donohoe R, Zelis R. Pericardial effusions in sarcoidosis. Chest 1979; 76: 476-478.
35. Fahy GJ, Marwick T, McCreery CJ, Quigley PJ, Maurer BJ. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 1996; 109: 62-66.
36. Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, et al. Cardiac sarcoidosis. Am Heart J 2009; 157: 9-21.
37. Garrett J, O’Neill H, Blake S. Constrictive pericarditis associated with sarcoidosis. Am Heart J 1984; 107: 394.
38. Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, et al. Cardiac sarcoidosis: Epidemiology, characteristics and outcome over 25 years in a nationwide study. Circulation 2015; 131: 624-632.